The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.

Key Challenges

Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.

Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

Erbitux (cetuximab) - February 2016
Rituxan (rituximab) - September 2016
Herceptin (trastuzumab) - June 2019
Avastin (bevacizumab) - July 2019
Aranesp (darbepoetin alfa) - May 2024
Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.View less

Specialty and Fine Chemicals

Cosmetic Ingredients

Food Ingredients

Aerospace and Defense

Automotive and Transportation

Consumer Electronics

Construction Engineering

Industrial Automation and Machinery

Semiconductors

Smart Technologies

Information and Communication Technology

Biotechnology Published Insights

Glycomics Market

Published Date : Mar 2024

The global glycomics market is estimated to be valued at USD 1.99 BN in 2024 and is expected to exhibit a CAGR of 13.5% during the forecast period (2024-2031). Glycomics is the large-scale study of the entire complement of sugars, known as the glycome. Glycomics seeks... View more

Spatial Omics Market

Published Date : Mar 2024

Spatial omics technologies have emerged during the last few years and have changed the way we understand multicellular biological systems, which includes genomics, transcriptomics, proteomics, and metabolomics. Conventional proteom... View more

Cell Culture Market

Published Date : Mar 2024

The global cell culture market is estimated to be valued at USD 22.56 Bn in 2024 and is expected to exhibit a CAGR of 11.8% during the forecast period (2024-2031). The cell culture market has seen significant growth in the last few decades driven by advancements in bi... View more

Synthetic Biology Market

Published Date : Mar 2024

The global synthetic biology market is estimated to be valued at USD 17.88 Bn in 2024 and is expected to exhibit a CAGR of 22.3% during the forecast period (2024-2031). Synthetic biology is an emerging field that applies engineering principles to biology. It involves ... View more

Influenza Vaccines Market

Published Date : Mar 2024

Global influenza vaccines market is estimated to be valued at USD 8.30 BN in 2024 and is expected to exhibit a CAGR of 7.1% during the forecast period (2024-2031). Influenza vaccines have been an important element of preventive healthcare for decades. The influenza vi... View more

Next Generation Sequencing Market

Published Date : Mar 2024

Global next generation sequencing market is estimated to be valued at USD 16.51 Bn in 2024 and is expected to exhibit a CAGR of 14.5% during the forecast period (2024-2031). Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies tha... View more

Crispr Technology Market

Published Date : Mar 2024

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also ... View more

Swine Fever Vaccine Market

Published Date : Mar 2024

There are two types of swine fever – Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of th... View more

Cell Expansion Market

Published Date : Mar 2024

Cell expansion is the production of daughter cells from a single cell. Cell expansion requires the creation of new cell wall material and organized releasing of the wall to allow it to stretch and increase in area. Cell-wall-associated proteins are key components in c... View more

Ipv Vaccines Market

Published Date : Mar 2024

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot. ... View more

Global Cholera Vaccines Market

Published Date : Feb 2024

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inad... View more

Global Multiomics Market

Published Date : Feb 2024

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biologic... View more

Global Induced Pluripotent Stem Cells Market

Published Date : Feb 2024

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternati... View more

Global Primary Cell Culture Market

Published Date : Feb 2024

Primary cell culture is the process of growing cells derived directly from animal or plant tissues in an artificial, controlled environment. This allows the cells to retain their original form and function outside their original environment. Primary cell culture maint... View more

Global Phosphoramidite Market

Published Date : Feb 2024

Phosphoramidite stands as a cornerstone in the synthesis of DNA and RNA molecules, playing a pivotal role in diverse fields such as biotechnology and pharmaceuticals. This compound serves as a crucial building block, enabling controlled and precise oligonucleoti... View more

Protein Stability Analysis Market

Published Date : Feb 2024

Protein stability analysis involves studying the physical and chemical stability of protein therapeutics during development and storage. Proteins can undergo various degradations such as aggregation, fragmentation, deamidation, and oxidation when exposed to stress con... View more

Bioburden Testing Market

Published Date : Feb 2024

Bioburden testing refers to the detection and quantification of microorganisms present in or on a product, raw material, or surface. Bioburden testing helps monitor the quality of pharmaceutical and healthcare products by ensuring materials and equipment used in produ... View more

Global Dna Nanotechnology Market

Published Date : Jan 2024

DNA nanotechnology is an emerging field that utilizes the unique properties of DNA to engineer novel arrangements of DNA, and manipulate materials at the nanoscale level. By exploiting the highly specific binding properties of DNA base pairs, DNA nanotechnology allows... View more

Biotechnology Published Insights

Credibility and Certifications